HCC: We Prefer Fractionation Versus Dose Reduction
Int J Radiat Oncol Biol Phys
.
2023 Feb 1;115(2):277.
doi: 10.1016/j.ijrobp.2022.08.061.
Authors
Carla Hajj
1
,
Christopher H Crane
1
Affiliation
1
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
PMID:
36621228
DOI:
10.1016/j.ijrobp.2022.08.061
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular* / radiotherapy
Dose Fractionation, Radiation
Drug Tapering
Humans
Liver Neoplasms* / diagnostic imaging
Liver Neoplasms* / radiotherapy